Dr Reddy's Laboratories Ltd Stock News

Sun Pharma the biggest gainer among Sensex firms with a jump of 3.99 per cent, followed by TCS, NTPC, Wipro, Tech Mahindra, Dr Reddy''s, UltraTech Cement and Infosys

Brokerage Radar | Jefferies has initiated coverage on Bajaj Finance shares whereas Macquarie has removed Asian Paints'' stock from its marquee buy list. Meanwhile, Macquarie has added Titan''s stock to its marquee list and believes the jewellery company should benefit from the continued momentum in market share gains. Here is a list of brokerage calls for this morning:

The second round of bids are expected by March-end, the sources said. Investment banks Edelweiss and Mape Advisory are running the sale process. Leading investors ChrysCapital, Sequoia and the promoters plan to sell Curatio Healthcare, at a valuation of ₹2,000-2,300 crore ($300 million), ET first reported in January. Feelers were sent to top buyout funds and domestic pharma majors such as Dr Reddy''s, Torrent and Cadila Healthcare.

Some recovery in the financial space and gains in heavyweights such as ITC, Dr Reddy''s and Tech Mahindra helped the headline indices trim their intraday losses.

BSE benchmark Sensex plummeted 778 points to close below the 55,500-level on Wednesday following a broad-based selloff in global markets as the Russia-Ukraine crisis escalated. The 30-share BSE index ended 778.38 points or 1.38 per cent lower at 55,468.90. Similarly, the NSE Nifty plunged 187.95 points or 1.12 per cent to 16,605.95. Maruti was the top loser in the Sensex pack, shedding 6 per cent, followed by Dr Reddy''s, Asian Paints, ICICI Bank, HDFC and HDFC Bank.

Maruti was the top loser in the Sensex pack, shedding 6 per cent, followed by Dr Reddy''s, Asian Paints, ICICI Bank, HDFC and HDFC Bank.

Brokerage Radar: Jefferies has upgraded its rating on shares of Biocon to ''buy'' while CLSA believes geopolitical tensions might add to supply chain challenges in the short term for automakers. Here are top brokerage calls for this morning:

As many as 77 stocks from BSE 500 index which hit their 52-week low in the morning session on Thursday, include Dr Reddy''s, Exide Industries, HDFC Life, Apollo Tyres, BPCL, DCB Bank, HDFC Asset Management Company Ltd, Gillette India Ltd, and Wockhardt Ltd.

CLSA sees a favourable risk-to-reward ratio in shares of Dr Reddy''s Laboratories, Cadila Healthcare and Torrent Pharma. The brokerage has upgraded Torrent Pharma to ''buy'' from ''outperform'' with an unchanged target price of ₹3,550.

Indian equity benchmark indices opened gap-down on Tuesday tracking weak global markets amid rising Russia-Ukraine tensions. All the 30 Sensex constituents were in the negative territory. Losses were led by Dr Reddy''s, Asian Paints, TCS, L&T, IndusInd Bank, HDFC twins, Bajaj Finserv, whose stock were down 2-3 percent.

Sensex plunges 1,000 pts, Nifty below 16,900, breaches 200-DMA; Smallcap index slides 2%; India VIX surges 16%; L&T, Dr Reddy''s Labs drop 3% each.

As many as five top 100 companies have reported over 150 per cent surge in net profit for the December quarter, with Dr Reddy''s Labs leading the chart with a 54 times jump (5,297 per cent) in bottom line on a year-on-year basis. All these stocks are a ''buy'' with an upside target of 19-25 per cent, suggest consensus estimates. Stock Ideas

The acquisition of the product is expected to strengthen the company’s presence in the inhalation respiratory market segment, Mankind Pharma said.

Mankind Pharma on Wednesday said it has inked a pact with Dr Reddy''s Laboratories to acquire two brands -- Combihale and Daffy. While Combihale is used for the treatment of asthma and chronic obstructive pulmonary disease, Daffy is a soap-free moisturising

Mankind Pharma on Wednesday said it has inked a pact with Dr Reddy''s Laboratories to acquire two brands -- Combihale and Daffy. While Combihale is used for the treatment of asthma and chronic obstructive pulmonary disease, Daffy is a soap-free moisturising bar for infants. Mankind Pharma said the market for Combihale is valued at Rs 900 crore growing at 14 per cent.